throbber
T. Yagami
`K. Kitagawa
`C. Aida
`H. Fujiwara
`S. Futaki
`
`Stabilization of a tyrosine
`O-sulfate residue by a
`cationic functional group:
`formation of a conjugate
`acid±base pair
`
`Authors' af®liations:
`
`Key words: cholecystokinin; conjugate acid±base pair;
`
`T. Yagami, National Institute of Health Sciences,
`
`desulfation; gastrin II; liquid secondary-ion mass spectrometry;
`
`Tokyo, Japan.
`
`MALDI-TOFMS; sulfated tyrosine
`
`K. Kitagawa, C. Aida and H. Fujiwara, Niigata
`
`College of Pharmacy, Niigata, Japan.
`
`S. Futaki, Institute for Chemical Research, Kyoto
`
`University, Japan.
`
`Correspondence to:
`Correspondence to: Dr Kouki Kitagawa
`
`Niigata College of Pharmacy
`
`5-13-2 Kamishin'ei-cho
`
`Niigata
`
`Niigata 950-2081
`
`Japan
`
`Tel.: 81-25-268-1241
`
`Fax: 81-25-268-1230
`
`E-mail: kouki@niigata-pharm.ac.jp
`
`Dates:
`
`Received 17 December 1999;
`
`Revised 7 March 2000;
`
`Accepted 19 May 2000
`
`To cite this article:
`
`Yagami, T., Kitagawa, K., Aida, C., Fujiwara, H. &
`
`Futaki, S. Stabilization of a tyrosine O-sulfate residue by a
`
`cationic functional group: formation of a conjugate acid±
`
`base pair.
`
`J. Peptide Res., 2000, 56, 239±249.
`
`Copyright Munksgaard International Publishers Ltd, 2000
`
`ISSN 1397±002X
`
`Abstract: Sulfated tyrosine [Tyr(SO3H)]-containing peptides
`showed characteristic peak patterns in their liquid secondary-ion
`
`mass spectrometry (LSIMS) spectra. Protonated molecules were
`
`desulfated more easily than their deprotonated counterparts.
`
`Therefore, the stabilities of the Tyr(SO3H) residues were well-
`re¯ected by peak patterns in their positive-ion spectra. These
`
`intrinsic peak patterns were investigated by comparing the
`
`behavior of each Tyr(SO3H) residue in acidic solution. As the
`peptide chain was lengthened and the number of cationic
`functional groups increased, the peak representing the [MH]+ of a
`
`Tyr(SO3H)-containing peptide became more prominent than that
`representing the desulfated [MH±SO3]+. These alterations in
`peptide structure also increased the stability of the Tyr(SO3H)
`residue in acidic solution. Based on the desulfation mechanism of
`
`an aryl monosulfate, we predicted that intramolecular cationic
`
`functional groups would stabilize Tyr(SO3H) residues by forming
`conjugate acid±base pairs (or salt bridges) both in the gaseous
`
`phase and in acidic solution. In accordance with this theory, Arg
`
`residues would take primary responsibility for this self-stabilization
`
`within Tyr(SO3H)-containing peptides. Moreover, a long peptide
`backbone was expected to have a weak protective effect against
`desulfation of the [MH]+ in the gaseous phase. Tyr(SO3H) residues
`were also stabilized by adding an external basic peptide containing
`
`multiple Arg residues. Formation of such intermolecular acid±base
`
`pairs was demonstrated by matrix-assisted laser desorption/
`
`ionization time-of-¯ight mass spectrometry (MALDI-TOFMS) which
`
`detected conjugated peptide ions. The energetically favorable
`
`formation of conjugate acid±base pairs prompted by Tyr(SO3H)
`residues might be a driving force for protein folding and protein±
`
`protein interaction.
`
`239
`
`-239-
`
`
`
`
`MAIA Exhibit 1021
`MAIA V. BRACCO
`IPR PETITION
`
`

`

`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`Abbreviations: AcOH, acetic acid; AcONH4, ammonium acetate;
`Boc, tert-butyloxycarbonyl; CCK, cholecystokinin; DIPCDI,
`
`diisopropylcarbodiimide; DMF, N,N-dimethylformamide; Fmoc,
`
`¯uoren-9-ylmethyloxycarbonyl; FT-IR, Fourier transform infrared
`
`spectrometry; G-II, gastrin-II; HOBt, 1-hydroxybenzotriazole;
`
`LSIMS, liquid secondary-ion mass spectrometry; MALDI-TOFMS,
`
`matrix-assisted laser desorption/ionization time-of-¯ight mass
`
`spectrometry; NMM, N-methylmorpholine; Pbf,
`
`2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl; RP-HPLC,
`
`reversed-phase high-performance liquid chromatography; tBu,
`
`tert-butyl; TFA, tri¯uoroacetic acid
`
`The sulfation of tyrosine residues is one of the ubiquitous
`
`post-translational modi®cations of peptides and proteins
`
`(1±3). This modi®cation is catalyzed by tyrosylprotein
`
`sulfotransferase, a membrane-bound enzyme within the
`
`trans-Golgi compartment. It has been proposed that sulfate
`
`plays an important role in speci®c protein±protein interac-
`
`tions during protein transport. According to this theory,
`negative charges on tyrosine O-sulfate [Tyr(SO3H)] residues
`might participate in intermolecular recognition (3). They may
`
`also affect protein folding by interacting with cationic
`residues within Tyr(SO3H)-containing peptides. Despite its
`biological importance, this post-translational modi®cation is
`hard to detect. It is well known that Tyr(SO3H) residues tend
`to rapidly desulfate to Tyr under acidic conditions. Thus, due
`
`to their intrinsic acid lability, traditional analytical methods,
`
`for example amino acid analysis of the acid hydrolysate or
`
`Edman degradation, cannnot be performed on peptides and
`proteins containing Tyr(SO3H) residues.
`Since the late 1980s, mass spectrometry using soft-
`
`ionization techniques, such as fast atom bombardment
`
`ionization, MALDI and electrospray ionization, has seemed
`
`to be a very promising analytical tool for the examination of
`peptides and proteins containing Tyr(SO3H) residues (4±10).
`In previous studies, we observed characteristic fragmenta-
`
`tion patterns in the positive- and negative-ion LSIMS spectra
`of peptides containing multiple Tyr(SO3H) residues (11).
`Moreover, we selectively detected the [MH]+ of Tyr(SO3H)-
`containing peptides from crude peptide mixtures using
`
`_F\_ i
`_F\_
`R~°i""°H ..,..!.. R ~ 0 ~ - - R~OH
`+
`
`0
`
`-0-H '7
`-H· ~•H· 0 X
`+X -0 11
`-0- 11
`
`R
`
`0
`0
`+
`0-S--0- ~ R ~ g 0-S-0- X +
`x•
`II
`II
`o
`-
`o
`(X• : counterion)
`Figure 1. Plausible mechanism for desulfation and stabilization of a
`Tyr(SO3H) residue.
`
`Tyr(SO3H) residues rapidly decompose to Tyr residues in
`nonpolar organic solvents, as well as in strongly acidic
`
`solutions (14,15). Accordingly, we can rationally predict that
`the proton-surplus [MH]+ of Tyr(SO3H)-containing peptides
`rapidly loses its sulfate in the gaseous phase (a nonpolar
`
`the completely desulfated
`environment). As a result,
`[MH±nSO3]+, where n represents
`fragment
`ion,
`the
`number of Tyr(SO3H) residues, should appear prominently
`in the positive-ion spectrum. The remarkable lability of the
`[MH]+ also allows its selective detection by constant
`neutral-loss (80 amu) scanning. In contrast to [MH]+, the
`proton-de®cient [M±H]± of Tyr(SO3H)-containing peptides
`must be relatively stable even in the gaseous phase. We
`expect that at least one Tyr(SO3H) residue should remain
`intact without becoming an amphoteric ion subject to
`
`desulfation. As a result, the characteristic ladder fragmenta-
`tion pattern, [M±H±mSO3]± (m51,2,..., n±1), should appear
`in the negative-ion spectrum.
`
`From the same desulfation mechanism (Fig. 1), we
`predicted that Tyr(SO3H) residues become stable by forming
`conjugate acid±base pairs or ion pairs with cations other
`
`than protons. Intramolecular cationic functional groups are
`
`candidates for the conjugate base. If such conjugate acid±
`base pairs are actually formed, Tyr(SO3H) residues would
`become stable not only in acidic solutions, but also in the
`
`gaseous phase. In order to investigate this assumption, we
`®rst compared the stability of Tyr(SO3H) residues within
`various sulfated peptides in the gaseous phase and in acidic
`
`solution.
`
`constant neutral-loss (80 amu) scanning (12).
`
`Experimental Procedures
`
`Both the appearance of characteristic fragmentation
`patterns and the ability to selectively detect Tyr(SO3H)-
`containing peptides could be explained by a proposed
`
`Fluoren-9-ylmethyloxycarbonyl (Fmoc) amino acid deriva-
`
`tives and 2-chlorotrityl (Clt) resin (16) (substituted level;
`
`desulfation mechanism (13)
`
`(Fig. 1). According to this
`
`1.47 mmol/g) were purchased from Watanabe Chemical Co.,
`
`model,
`desulfation of
`aryl monosulfates,
`including
`Tyr(SO3H) residues, is catalyzed by protons and accelerated
`under nonpolar conditions. Indeed, it has been reported that
`
`Ltd. (Hiroshima, Japan). Other chemicals were of analytical
`
`grade. Authentic samples of tyrosine-O-sulfated Leu-enke-
`phalin [H-Tyr(SO3H)-Gly-Gly-Phe-Leu-OH] (17) and CCK-8
`
`240 | J. Peptide Res. 56, 2000 / 239±249
`
`-240-
`
`
`
`
`

`

`were obtained from the Peptide Institute, Inc. (Osaka, Japan).
`
`Peptides used in the MALDI-TOFMS study [H-RRLSSLRA-
`OH (S6-1), Ac-MLF-OH and H-KHG-NH2 (Bursin)] were
`purchased from Novabiochem (Tokyo, Japan). The amino
`
`acid composition of an acid hydrolysate was determined
`
`using a Hitachi 8500 model amino acid analyzer. FT-IR
`
`spectra were recorded on a Perkin±Elmer 1720 spectrometer.
`
`RP-HPLC was performed on a Hitachi L-6200 model.
`
`Synthesis of sulfated peptides
`
`CCK peptides and G-II peptides
`
`Human cholecystokinin (CCK) and gastrin-II (G-II) peptides
`
`(Table 1) were prepared using the facile solid-phase method
`
`developed by Kitagawa et al. (18). The purity of each peptide
`
`exceeded 98% on RP-HPLC. Details of their syntheses are
`
`reported elsewhere.
`
`N-Acetyl tyrosine-O-sulfated Leu-enkephalin
`
`N-Acetyl tyrosine-O-sulfated Leu-enkephalin was prepared
`
`using Fmoc-Leu-Clt-resin (0.15 mmol) as a starting mate-
`rial. Each residue including Fmoc-Tyr(SO3Na)-OH (19,20)
`was introduced using the DIPCDI/HOBt coupling protocol
`
`[Fmoc-amino acid (3 eq.), DIPCDI (3 eq.) and HOBt (3 eq.);
`90 min]. After introducing the N-terminal Tyr(SO3Na)
`residue, the free a-amino group was acetylated with acetic
`
`anhydride
`
`(1.0 mmol)
`
`in the
`
`presence
`
`of
`
`pyridine
`
`(1.0 mmol). The peptide-resin obtained (50 mg) was treated
`with a mixture of AcOH/tri¯uoroethanol/CH2Cl2 (1 : 1 : 3 v/
`v, 5 mL) for 20 min at 208C, then ®ltered. After the ®ltrate
`had been concentrated with a stream of N2, dry ether
`(50 mL) was added to it. The resultant precipitate was
`
`collected by centrifugation and lyophilized from 0.025 m
`NH4HCO3 (30 mL); weight 9.80 mg. Part of the crude
`peptide was puri®ed by RP-HPLC [HPLC conditions:
`column, Cosmosil 5C18-AR (103250 mm); elution system,
`
`Table 1. Amino acid sequences of CCK and G-II peptides
`
`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`a linear gradient of CH3CN/0.1 m AcONH4 (20±25% in
`60 min); ¯ow rate, 2.5 mL/min; absorbance was detected
`
`at 265 nm]. The integrity of the sulfate was con®rmed by
`FT-IR (1050 cm±1).
`
`CCK-12 derivatives
`[Lys4],
`[Leu4] and [Glu4]CCK-12,
`[H-Ile-Ser-Asp-X-Asp-
`Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2; X5Lys, Leu,
`or Glu], were prepared from 0.1 mmol of Fmoc-Asp (Clt
`resin)-Phe-NH2 (18,21) (Fig. 2). The DIPCDI/HOBt coupling
`protocol was used to elongate each derivative. After
`assembly, the protected peptide-resin (< 80 mg) was treated
`with a mixture of AcOH/tri¯uoroethanol/CH2Cl2 (1 : 1 : 3,
`4 mL) at 258C for 20 min; the detached peptide was then
`treated with 90% aqueous TFA (2 mL) at 08C for 7 h. The
`crude peptide was puri®ed by RP-HPLC [column, mBonda-
`sphere 5C18 100 AÊ
`(193150 mm); elution system, a linear
`gradient of CH3CN/0.1 m AcONH4 at a ¯ow rate of
`1.75 mL/min; absorbance was detected at 265 nm]. Yields
`
`of the puri®ed peptides were between 31 and 37% based on
`
`the protected peptide-resin. Amino acid ratios of the acid
`hydrolyzates were as follows: [Lys4]CCK-12, Asp 3.03, Ser
`0.90, Gly 1.00, Met 1.74, Ile 1.05, Tyr 1.00, Phe 0.96, Lys
`1.04, Trp ND (not determined); [Leu4]CCK-12, Asp 2.96, Ser
`0.88, Gly 1.00, Met 1.43, Ile 1.01, Leu 1.00, Tyr 0.98, Phe
`0.95, Trp ND; [Glu4]CCK-12, Asp 3.03, Ser 0.89, Glu 1.03,
`Gly 1.00, Met 1.53, Ile 1.04, Tyr 1.01, Phe 0.96, Trp ND. The
`integrity of the sulfate was con®rmed by FT-IR (1049 cm±1).
`The detected molecular mass (monoisotopic mass) of each
`
`peptide coincided with calculated values.
`
`Cionin
`
`The
`protochordate-derived
`cionin
`[H-Asn-Tyr(SO3H)-
`Tyr(SO3H)-Gly-Trp-Met-Asp-Phe-NH2] was prepared using
`the Fmoc-based solid-phase approach (22).
`
`CCK Peptides
`
`CCK-8
`
`CCK-12
`
`CCK-22
`
`CCK-33
`
`G-II Peptides
`
`H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
`
`H-Ile-Ser-Asp-Arg-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
`
`H-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
`
`H-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tyr(SO3H)-Met-Gly-Trp-
`
`Met-Asp-Phe-NH2
`
`mini gastrin-II (G-14)
`
`H-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr(SO3H)-Gly-Trp-Met-Asp-Phe-NH2
`
`little gastrin-II (G-17)
`
`Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr(SO3H)-Gly-Trp-Met-Asp-Phe-NH2
`
`big gastrin-II (G-34)
`
`Pyr-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr(SO3H)-Gly-Trp-
`
`Met-Asp-Phe-NH2
`
`J. Peptide Res. 56, 2000 / 239±249 | 241
`
`-241-
`
`
`
`
`

`

`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`9
`
`Fmoc-Asp-Phe-NH2
`
`0
`
`1~-
`i 1) AcOH I CF3CH~H I CH202
`
`CCK-12
`
`225nm
`
`Figure 2. Synthetic scheme for CCK-12 and
`its derivatives. Inset: RP-HPLC
`chromatogram of crude CCK-12 (X5Arg)
`obtained after deprotection. An asterisk
`shows the peak representing the desulfated
`peptide (CCK-12 nonsulfate). HPLC
`conditions [column, Cosmosil 5C18 AR
`(4.63150 mm); elution system, a linear
`gradient of CH3CN/0.1 M AcONH4
`(20±35% in 30 min); ¯ow rate, 1 mL/min;
`absorbance was detected at 225 nm].
`
`H-lle-Ser('eu)-Asp(O'eu)- X -Asp{O'Bu)-Tyr(S031-Met-Gly-Trp-Met-l-Phe-NH2
`
`2) 90% aqueous TFA (O "C)
`3) Preparative RP-HPLC
`H-lle-Ser-Asp- X -Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
`
`[ X = Arg(Pbf), Lys(Boc), Leu, or Glu(O'eu). ]
`O = 2-chlorotrityl resin
`IX = Arg, Lys, Leu, or Glu]
`
`Desulfation rates of Tyr(SO3H)-containing peptides in acidic
`solution
`
`counterparts are listed in Table 2, along with the molecular
`
`masses of the sulfated forms.
`
`HPLC-puri®ed G-17 (540 mg) was dissolved in an ice-cooled
`mixture of CH3CN and H2O (2 : 3 v/v, 500 mL) containing
`5% TFA, and then incubated at 378C. An aliquot of the
`solution was withdrawn at appropriate intervals (0.5, 1, 2, 3
`
`and 5 h) and immediately lyophilized. Each lyophilizate was
`reconstituted with ice-cooled 15% CH3CN in 0.1 m
`AcONH4 (100 mL), 20 mL of this solution was then applied
`to RP-HPLC [column, Cosmosil 5C18-AR (3.93150 mm);
`elution system, a linear gradient of CH3CN/0.1 m AcONH4
`(17±32% in 30 min); ¯ow rate,1 mL/min; absorbance was
`
`detected at 225 nm].
`
`Desulfation of the other peptides was similarly examined.
`
`Retention times of intact peptides and their nonsulfated
`
`Mass spectrometry
`
`LSIMS spectra were obtained using a VG ZAB-2SE double-
`
`focusing mass spectrometer (VG Analytical, Ltd, Manche-
`
`ster, UK) with an OPUS operating data system. Each HPLC-
`puri®ed peptide was dissolved in a mixture of H2O/CH3CN
`(1 : 1) at a concentration of < 10 mg/mL. Glycerol, thiogly-
`cerol and m-nitrobenzyl alcohol were used as the matrix,
`either neat or in combination. Typically, 2 mL of matrix was
`deposited on the target, and 1 mL of the peptide solution was
`added and mixed with the matrix. Ionization of the sample
`was performed using < 1 mA of cesium ions which were
`applied with a cesium ion gun. All spectra were recorded at
`
`Table 2. Molecular masses and retention times of CCK and G-II peptides
`
`tR on HPLC (min)a
`
`Temp
`
`Formula and molecular mass
`
`Sulfate
`
`Nonsulfate
`
`CCK Peptides
`
`20±35% in 30 min
`
`CCK-8
`
`CCK-12
`
`CCK-22
`
`CCK-33
`
`C49H62N10O16S3
`
`C68H95N17O23S3
`
`C117H173N35O39S3
`
`C167H263N51O52S4
`
`[Lys4]CCK-12
`
`C68H95N15O23S3
`
`[Leu4]CCK-12
`
`C68H94N14O23S3
`
`[Glu4]CCK-12
`
`C67H90N14O25S3
`
`G-II Peptides
`
`G-14
`
`G-17
`
`G-34
`
`C85H109N17O30S2
`
`C97H123N20O34S2
`
`C176H251N43O56S2
`
`1142.4b
`
`1613.6b
`
`2790.0c
`
`13.4
`
`12.0
`
`15.1
`
`3945.5c
`
`24.7d
`
`1585.6b
`
`8.7
`
`1570.6b
`
`11.8
`
`1586.5b
`
`5.5
`
`17±32% in 30 min
`
`1913.0c
`
`2177.3c
`
`3929.3c
`
`14.3
`
`15.0
`
`17.7
`
`16.4
`
`15.4
`
`17.3
`
`26.5d
`
`12.4
`
`16.2
`
`9.8
`
`18.0
`
`17.9
`
`19.5
`
`a. HPLC conditions: column, Cosmosil 5C18 AR (4.63150 mm); elution system, a linear gradient of
`CH3CN/0.1 M AcONH4; ¯ow rate,1 mL/min; absorbance was detected at 225 nm. b. Calculated as
`monoisotopic mass. c. Calculated as average mass. d. 20±40% in 60 min at a ¯ow rate of 1 mL/min.
`
`242 | J. Peptide Res. 56, 2000 / 239±249
`
`-242-
`
`
`
`
`

`

`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`an accelerating voltage of 8 kV and at a resolution of 1000.
`The scan rate was chosen so that each scan took < 20 s, and
`data from several scans were generally summed over the
`
`22 and 3946.5 for CCK-33) became more prominent than
`that of the desulfated [MH±SO3]+ which exhibited negligible
`intensity. These peak patterns were not signi®cantly
`
`course of 1±2 min. Data accumulated in multichannnel
`
`analyzer (MCA) mode were processed by standard practices
`
`employed by the software. No corrections were made to
`
`affected by changing the matrix for ionization. In contrast,
`the peak representing the [M±H]± of each peptide (m/z
`1141.3 for CCK-8, 1612.5 for CCK-12, 2788.9 for CCK-22
`
`account for background from the matrix. Mass calibration
`
`and 3944.6 for CCK-33) appeared consistently as the base
`
`was carried out using clusters of cesium iodide to set an
`
`peak in the negative-ion LSIMS spectra. We could not detect
`
`external standard. The pseudo-molecular ions of peptides
`
`any desulfated CCK-8 on a RP-HPLC chromatogram even
`
`that exceed a molecular mass of 1700 Da, are shown as
`
`after CCK-8 was exposed to a 3-min measurement of its
`
`average masses (Table 2).
`
`LSIMS spectrum in the positive-ion mode.
`
`In order to examine the possibility that desulfation could
`
`occur in the matrix during mass spectrometric analysis, CCK-
`
`8 was dissolved in glycerol and measured. After being
`
`bombarded for 3 min with cesium ions, the sample was
`
`withdrawn from the target and examined by RP-HPLC
`[column, Wakosil-II 5C18 (4.63150 mm); elution system, a
`linear gradient of CH3CN/0.1 m AcONH4 (15±45% in
`30 min); ¯ow rate, 1 mL/min; absorbance was detected at
`
`280 nm].
`
`MALDI-TOFMS
`
`MALDI-TOFMS spectra were obtained using a Shimadzu/
`
`Kratos Kompact MALDI IV time-of-¯ight mass spectro-
`
`meter ®tted with a nitrogen laser (337 nm). Either CCK-8 or
`cionin was dissolved in H2O/CH3CN (1 : 1, v/v) and mixed
`with 5 eq. of a peptide (S6-1, Ac-MLF-OH or H-KHG-NH2).
`The mass spectrum of each mixture was recorded in linear
`
`mode at a 20-kV accelerating voltage using sinapinic acid as
`
`the matrix for ionization. Pseudo-molecular ions registered
`
`on MALDI-TOFMS spectra as average masses.
`
`Results
`
`LSIMS spectra of CCK peptides
`
`The positive- and negative-ion LSIMS spectra of CCK
`
`peptides are shown in Fig. 3. In the positive-ion spectrum
`
`of CCK-8 (the shortest CCK peptide examined), a prominent
`[MH±SO3]+ peak (m/z 1063.3) accompanied a weak [MH]+
`peak (m/z 1143.3). However, there were signi®cant changes
`
`within the peak patterns in the positive-ion spectra of CCK
`
`peptides as peptide lengths were altered. In the spectrum of
`CCK-12, the [MH]+ (m/z 1614.5) and the [MH±SO3]+ (m/z
`1534.6) were detected at an almost equal intensity. How-
`
`ever, in the spectra of CCK-22 and CCK-33, the peak
`representing the [MH]+ of each peptide (m/z 2791.1 for CCK-
`
`LSIMS spectra of G-II peptides
`
`The positive- and negative-ion LSIMS spectra of G-II
`
`peptides are shown in Fig. 4. In the positive-ion spectra of
`
`G-14 and G-17, the base peaks were the desulfated [MH±
`SO3]+ (m/z 1833.7 for G-14 and 2098.4 for G-17). The peaks
`corresponding to the [MH]+ (m/z 1913.8 for G-14 and 2178.1
`for G-17) were very weak. In the positive-ion spectrum of G-
`34, a prominent [MH]+ peak (m/z 3929.9) accompanied a
`weak [MH±SO3]+ peak (m/z 3849.0). The [M±H]± peak of
`each peptide (m/z 1911.9 for G-14, 2176.3 for G-17, and
`
`3927.8 for G-34) appeared consistently as the base peak in
`
`the negative-ion LSIMS spectra.
`
`Stability of the Tyr(SO3H) residues in acidic solution
`
`In general, short peptides tended to desulfate more easily
`
`than longer ones in acidic solution (Fig. 5). This tendency
`
`was especially pronounced in CCK peptides; the order of the
`
`desulfation rate was CCK-8.CCK-12.CCK-22.CCK-33.
`
`However, size dependency could not be substantiated in G-II
`
`peptides; G-17 was most susceptible to desulfation and G-14
`
`was exceptionally stable in acidic solution.
`
`Effects of cationic functional groups in Tyr(SO3H)-containing
`peptides on the positive-ion LSIMS spectra and desulfation rates
`
`First, the positive-ion LSIMS spectra of tyrosine-O-sulfated
`
`Leu-enkephalin and its N-acetylated derivative were com-
`
`pared. In the spectrum of sulfated Leu-enkephalin, the
`[MH]+ peak (m/z 636.2) and the desulfated [MH±SO3]+ peak
`(m/z 556.3) were detected at comparable intensities. In
`contrast, a prominent [MH±SO3]+ peak (m/z 598.3) and a
`weak [MH]+ peak (m/z 678.3) were detected in the spectrum
`of the N-acetylated derivative. The relative dominance of
`[MH]+ over [MH±SO3]+ was well correlated with the stability
`
`J. Peptide Res. 56, 2000 / 239±249 | 243
`
`-243-
`
`
`
`
`

`

`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`10
`BO CCK-8
`60
`
`1063. 3
`[M+H-S03]+
`
`40
`
`20
`
`[M+H-S04]' ..._
`
`[M+H]'
`1143 .3
`
`CCK-8
`
`10
`
`BO
`
`60
`,o
`20
`
`1141.3
`-[M-H]"
`
`Figure 3. LSIMS spectra of human CCK
`peptides. A mixture of glycerol/thioglycerol
`(1 : 1) was used as the matrix for ionization.
`
`9 0
`
`9 0
`
`1000
`
`10
`BO CCK-12
`60
`,o
`20
`
`[M+H-S03]+
`
`161'. 5
`-[M+H]'
`
`1350 1'00 1,so 1500 1550 1600 1650
`2791.1
`-[M+H]'
`
`10
`BO CCK-22
`60
`•o
`20
`
`0
`
`2550 2600 2650 2700
`
`10
`BO CCK-33
`60
`
`40
`
`20
`
`m/z
`
`10
`
`BO
`
`60
`,o
`20
`
`m./z
`
`10
`
`BO
`
`60
`
`40
`
`20
`
`m/ z
`
`10
`
`BO
`
`60
`,o
`20
`
`9 0
`
`9 0
`
`CCK-12
`
`1000 1050 1100 1150
`16 2 . 5
`-[M-H)"
`
`m/z
`
`1350 1'00 1'50 1500 1550 1600 1650
`2788. 9
`-[M-H)"
`
`CCK-22
`
`m/z
`
`2550 2600 2650 2700
`
`m/z
`
`3700 3750 3800 3850 3900 3950
`
`m/z
`
`3700 3750 3800 3850 3900 3950
`
`m/z
`
`Positive
`
`Negative
`
`of the Tyr(SO3H) residues in acidic solution (data not
`shown).
`
`Second, CCK-12 derivatives with different residues at the
`X position [H-Ile-Ser-Asp-X-Asp-Tyr(SO3H)-Met-Gly-Trp-
`Met-Asp-Phe-NH2] were examined. The [M±H]± peak of
`each peptide consistently formed the base peak in their
`
`negative-ion LSIMS spectra (data not shown). In contrast,
`
`their peak patterns changed signi®cantly depending on the X
`
`residue in their positive-ion spectra (Fig. 6A, and Fig. 3 for
`
`CCK-12: X5Arg). When the X residue was a basic amino
`acid (Arg or Lys), an intense peak corresponding to [MH]+
`was recorded. Whereas, the desulfated [MH±SO3]+ became
`the prominent peak if Leu or Glu composed the X residue.
`The relative dominance of [MH]+ over [MH±SO3]+ correlated
`well with the acid stability of the Tyr(SO3H) residue in each
`CCK-12 derivative (Fig. 6B).
`
`10~
`90
`BO G-14
`70
`60
`so
`,o
`30
`20
`10
`
`1833. 7
`[M+H-SO:i]+
`
`[M+H-S04]'
`
`[M+H]'
`1913 . B
`
`1650 1700 1750 1800 1850 1900 1950
`2098 . 4
`
`10
`
`m/z
`
`G-14
`
`10
`90
`BO
`70
`60
`so
`,o
`30
`20
`10
`0
`
`[M-H-SOa]-
`
`2096.7
`
`1650 1700 1750 1800 1850 1900 1950
`2176.3
`-[M-H)"
`
`G-17
`
`10
`go·
`BO
`70
`60
`so
`,o
`30
`20
`10
`0
`1900 1950 2000 2050 2100 2150 2200
`3927. 8
`10
`90
`-[M-H]"
`BO G-34
`70
`60
`so
`,o
`30
`20
`10
`0
`3650 3700 3750 3800 3850 3900 3950
`
`Figure 4. LSIMS spectra of human G-II
`peptides. A mixture of glycerol/thioglycerol
`(1 : 1) was used as the matrix for ionization.
`
`m/z
`
`m/z
`
`m/z
`
`,.,.
`
`m/z
`
`[M+H-SO:i]+
`
`[M+H]'
`
`2178 .1
`
`90 G-17
`BO
`70
`60
`so
`•o
`30
`20
`10
`0
`1900 1950
`10
`90
`BO G-34
`70
`60
`so
`,o
`30
`20
`10
`0
`3650 3700 3750 3800 3850 3900 3950
`
`2000 2050 2100 2150 2200
`3929 . 9
`-[M+H] '
`
`[M+H-SOaJ'
`3849 . 0
`
`Positive
`
`Negative
`
`244 | J. Peptide Res. 56, 2000 / 239±249
`
`-244-
`
`
`
`
`

`

`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`B
`
`100
`
`..
`..
`
`-0- G •14
`
`-0--- G-34
`
`G-17
`
`70
`
`..
`. ..
`
`...
`
`. ..
`
`, ..
`Time (h)
`
`50
`
`, ..
`
`2.0
`
`...
`
`..•
`
`, ..
`
`A
`'"'
`..
`..
`.. -- CCK-12
`
`---- CCK-33
`
`-0- CCK-22
`
`-0- CCK-8
`
`70
`
`50
`
`..•
`
`Remaining sulfated peptide (%)
`
`Figure 5. Desulfation rates of (A) CCK and
`(B) G-II peptides in a solution containing 5%
`TFA. Each experiment was run twice and
`the averages plotted.
`
`1.0
`
`2.0
`
`Effects of externally added peptides on the positive-ion MALDI-
`
`TOFMS spectra of Tyr(SO3H)-containing peptides
`
`The positive-ion MALDI-TOFMS spectrum of CCK-8 mixed
`
`in advance with a cationic peptide (S6±1) is shown in
`
`Fig. 7A. The intermolecularly conjugated peptide-ions,
`[CCK-8+S6-1+H]+ (m/z 2102.4) and [23CCK-8+S6-1+H]+
`(m/z 3245.1), were intensely detected. Moreover, these
`
`[cionin+ S6-1+H]+
`[23cionin
`and
`2214.9)
`(m/z
`S6-1;
`+ S6-1+H]+ (m/z 3311.1; Fig. 8A). In contrast, when cionin
`was premixed with Bursin, a completely desulfated fragment
`ion, [cionin + H±2SO3]+ (m/z 1097.4), formed the base peak.
`No conjugated peptide ions were detected in the MALDI-
`
`TOFMS spectrum of this mixture (Fig. 8B).
`
`conjugated peptide ions did not lose their sulfates.
`
`In
`
`Discussion
`
`contrast, no conjugated peptide ions were detected in the
`
`MALDI-TOFMS spectrum of a mixture of nonsulfated CCK-
`
`8 and S6-1 (Fig. 7B). Conjugated peptide ions were also not
`
`detected in the MALDI-TOFMS spectra of CCK-8 when it
`
`Very recently, we developed a facile solid-phase method for
`the synthesis of Tyr(SO3H)-containing peptides (18). Using
`this method, we prepared human CCK and G-II peptides
`
`was premixed with Ac-MLF-OH or Bursin (data not shown).
`Cionin, a peptide containing two Tyr(SO3H) residues, also
`formed conjugated peptide ions when it was premixed with
`
`without any dif®culties. These peptides with various chain
`
`lengths and cationic functional groups were studied with
`
`regard to their degree of
`
`intramolecular conjugation,
`
`(M+H-S03t 1506.7 -
`
`1586.6
`-(M+Ht
`
`A
`10
`
`X=Lys
`
`B
`
`100
`
`90
`
`80
`
`70
`
`-0-- CCK-12
`60 -+-- (Lys)CCK-12
`-0-- (Glu)CCK-12
`---½-
`(Leu)CCK-12
`
`Remaining sulfated peptide (%)
`
`50
`0.0
`
`1.0
`
`2.0
`3.0
`Time (h)
`
`4.0
`
`5.0
`
`J. Peptide Res. 56, 2000 / 239±249 | 245
`
`10
`80
`60
`40
`20
`0
`1300
`
`X=Leu
`
`1350 1400 1450
`
`1500 1550 1600
`1491.7
`
`m/z
`
`(M+H-S03t _
`
`[M+Ht
`1571.6
`
`1350 1400 1450 1500 1550 1600
`1507.7
`(M+H-S03t_
`
`m/z
`
`X=Glu
`
`1459 .6
`
`[M+Ht
`1588.6
`
`10
`80
`60
`40
`20
`0
`
`Per cent
`
`1500 1550 1600
`m/z
`1350 1400 1450
`Figure 6. (A) Positive-ion LSIMS spectra of CCK-12 derivatives [H-Ile-Ser-Asp-X-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2]. See Fig. 3 for
`the positive-ion LSIMS spectra of CCK-12 (X5Arg). (B) Desulfation rates of CCK-12 and its derivatives in a solution containing 5% TFA.
`
`-245-
`
`
`
`
`

`

`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`(S6-1 + Ht
`
`·~··
`
`,/ [CCK-8 + H- S03)+
`
`[CCK-8 + S6-1 + HJ+
`2102.4
`
`(2 x CCK-8 + S6-1 + Ht
`32~5.1
`
`1000
`
`1500
`
`2000
`
`2500
`
`3000
`
`[S6-1 + HJ+
`15~.3
`
`Mass/Charge
`
`,t [CCK-8(N.S.) + Ht
`
`A
`
`B
`
`%Int
`100
`
`..
`..
`..
`
`20
`
`%Int
`100
`
`..
`..
`..
`
`20
`
`1000
`
`1500
`
`2000
`
`2500
`
`3000
`
`3500
`
`4000
`
`Mass/Charge
`Figure 7. Positive-ion MALDI-TOFMS spectra of (A) CCK-8 premixed with S6-1 (H-RRLSSLRA-OH) and (B) nonsulfated CCK-8 premixed with
`S6±1.
`
`speci®cally, that involving the Tyr(SO3H) residue. Peak
`patterns in their LSIMS spectra, especially those in their
`
`positive-ion spectra, were not due to preferential desorbance
`
`of contaminating impurities; homogeneity of the peptides
`and the integrity of each Tyr(SO3H) residue were con®rmed
`using several analytical methods in addition to mass
`
`spectrometry (HPLC, FT-IR). The possibility of desulfation
`
`in the matrix was also excluded.
`
`Several notable features were observed in the positive-ion
`
`LSIMS spectra of CCK and G-II peptides (Figs 3, 4). One
`distinct characteristic was that the [MH]+ peak became
`dominant over the peak representing the desulfated [MH±
`SO3]+ as the peptide chains were lengthened. This can be
`explained in part by speculating that long peptide chains
`protect labile Tyr(SO3H) residues against proton-catalyzed
`desulfation. The `protecting effect' of long peptide chains
`
`[Cionin + S6-1 + Hi+
`
`221_4.t
`
`[S6-1 + HJ+
`K~.I
`
`I
`,~ ..
`
`[Clonln + H- 2S03i+
`
`(2 x Clonln + S6-1 + HJ+
`J:3~1.1
`
`1000
`
`1500
`
`2000
`
`2500
`
`,~ ..
`
`[Clonln + H-2S03i+
`
`Mass/Charge
`
`....
`
`A
`
`B
`
`%Int.
`100
`
`..
`..
`..
`
`20
`
`%Int.
`100
`
`..
`..
`..
`
`20
`
`3500
`
`3500
`
`....
`
`1000
`
`1500
`
`2000
`
`2500
`
`....
`
`Mass/Charge
`Figure 8. Positive-ion MALDI-TOFMS spectra of (A) cionin premixed with S6-1 and (B) cionin premixed with H-KHG-NH2 (Bursin).
`
`246 | J. Peptide Res. 56, 2000 / 239±249
`
`-246-
`
`
`
`
`

`

`may be attributable to their large number of carbonyl oxygen
`
`which may result from a decrease in the effectiveness of
`
`atoms. These might collectively capture surplus protons
`from [MH]+ in the gaseous phase and prevent the formation
`of amphoteric ions which are required for desulfation
`
`ionic interactions due to the absence of Arg residues (Fig. 4).
`Intramolecular conjugation of Tyr(SO3H) residues with Arg
`residues should be effective in the gaseous phase as well as
`
`Yagami et al . Stabilization of a tyrosine O-sulfate in a peptide
`
`(Fig. 1). A second characteristic of their LSIMS spectra was
`that G-II peptides produced a desulfated [MH±SO3]+ more
`readily than CCK peptides. This observation cannot be
`
`The disparate stability of
`
`explained solely by the `protecting effect' described above.
`respective Tyr(SO3H)
`residues in the gaseous phase must be due to structural
`
`their
`
`in solution.
`
`The stabilization afforded by the formation of conjugate
`
`acid±base pairs (or salt bridges) is also expected to result
`from the conjugation of Tyr(SO3H) residues with a- or e-
`amino groups within peptides. Two sets of experiments, in
`
`which the lengths of the peptide chains were ®xed to
`
`differences between CCK peptides and G-II peptides
`
`exclude the `protecting effect' of the peptide backbones, gave
`
`(Table 1).
`We also examined the stability of Tyr(SO3H) residues in
`acidic solution (Fig. 5). The observed results can be
`
`summarized as follows:
`
`(i)
`
`in general, desulfation was
`
`retarded as peptide chains were lengthened, and (ii)
`Tyr(SO3H) residues in G-II peptides tended to desulfate
`more rapidly than those in CCK peptides. The `protecting
`
`results that were consistent with this prediction. First, the
`
`peak patterns of sulfated Leu-enkephalin and its N-
`
`acetylated derivative were compared. As expected, desul-
`fated [MH±SO3]+ formed the dominant peak in the spectrum
`of the N-acetylated derivative in which the Tyr(SO3H)
`residue cannot form any stabilizing ionic interactions.
`
`Second,
`
`four CCK-12 derivatives were examined with
`
`effect' of long peptide chains is probably not effective in
`
`respect
`
`to their peak patterns in LSIMS spectra and
`
`acidic solutions where desulfation-catalyzing protons are
`
`desulfation rates in acidic solution. The positive-ion spectra
`
`present in excess. We again need to consider the structural
`
`of peptides having cationic residues (X5Arg or Lys) were in
`
`differences between these two series of peptides to explain
`the diverse susceptibilities of their Tyr(SO3H) residues to
`desulfation.
`
`As already mentioned, a proton-catalyzed mechanism has
`
`been proposed which is based on the desulfation of aryl
`monosulfates (ArO±SO3H) in acidic solutions (13) (Fig. 1).
`According to this theory, if aryl monosulfates form ion pairs
`±X+), they
`with counterions other than protons (ArO±SO3
`should be less apt to decompose than their proton-donating
`forms (ArO±SO3H). This stabilization can be explained by
`assuming that a higher energy barrier would have to be
`
`overcome in order to form intermediate amphoteric ions
`
`contrast to those peptides having neutral residues (X5Leu)
`
`or acidic residues (X5Glu) (Fig. 6 and Fig. 3 for CCK-12).
`Stabilities of the Tyr(SO3H) residues within the peptides in
`acidic solution correlated with the relative dominance of the
`[MH]+ peak over the [MH±SO3]+ peak in each LSIMS
`spectrum. These results reveal the `stabilizing effect' of
`
`neighboring guanidino groups and a- or e-amino groups on
`Tyr(SO3H) residues.
`The `stabilizing effect' provided by these cationic func-
`
`tional groups is based on their ability to form conjugate acid±
`base pairs with Tyr(SO3H) residues. Our results indicate that
`the guanidino group of Arg is preferentially chosen by the
`
`during the course of decomposition. Therefore, the different
`
`sulfate as its conjugate base. Indeed, guanidino cations were
`
`acid stabilities of CCK and G-II peptides can be mainly
`
`shown to have greater af®nities for the sulfate in glycosa-
`
`ascribed to the formation of conjugate acid-base pairs
`between Tyr(SO3H)
`groups that are in close proximity. Moroder & WuÈ nsch
`
`residues and cationic functional
`
`minoglycans than ammonium cations by Linhardt and co-
`
`workers (24,25). Furthermore, Arg is known to have the
`
`highest proton af®nity among the 20 common amino acids
`
`(23) also pointed out intramolecular ionic interactions
`between Tyr(SO3H) residues and Arg residues in CCK
`peptides.
`By referring to the acid stability of Tyr(SO3H) residues in
`solutio

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket